2006
DOI: 10.1002/chin.200642136
|View full text |Cite
|
Sign up to set email alerts
|

Design and Synthesis of Orally Efficacious Benzimidazoles as Melanin‐Concentrating Hormone Receptor 1 Antagonists.

Abstract: ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…The search for transient receptor potential vanilloid 1 (TRPV1) antagonists as potential analgesic has led to the discovery of a series of biaryl amides (such as those reported in Figure 8.35a) that suffer from a pharmacokinetic liability [170]. Other examples of benzimidazoles as aryl amides isosteres has also been reported as melanin-concentrating hormone receptor 1 (MCH R1) antagonists [171,172]. Other examples of benzimidazoles as aryl amides isosteres has also been reported as melanin-concentrating hormone receptor 1 (MCH R1) antagonists [171,172].…”
Section: Carboxamide Bioisosteresmentioning
confidence: 99%
“…The search for transient receptor potential vanilloid 1 (TRPV1) antagonists as potential analgesic has led to the discovery of a series of biaryl amides (such as those reported in Figure 8.35a) that suffer from a pharmacokinetic liability [170]. Other examples of benzimidazoles as aryl amides isosteres has also been reported as melanin-concentrating hormone receptor 1 (MCH R1) antagonists [171,172]. Other examples of benzimidazoles as aryl amides isosteres has also been reported as melanin-concentrating hormone receptor 1 (MCH R1) antagonists [171,172].…”
Section: Carboxamide Bioisosteresmentioning
confidence: 99%